Literature DB >> 16484770

Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.

Marco Mura1, Anna Ferretti, Orazio Ferro, Maurizio Zompatori, Alberto Cavalli, Mario Schiavina, Mario Fabbri.   

Abstract

BACKGROUND: Exertional dyspnea and exercise incapacity are the most prominent and disabling symptoms and the main contributors to health-related quality of life in patients with idiopathic pulmonary fibrosis (IPF).
OBJECTIVES: There are no comprehensive studies on pulmonary function tests (PFTs), dyspnea, exercise capacity and radiographic scores in IPF. We therefore sought to investigate the functional variables that can predict dyspnea, exercise capacity and disease extent in IPF.
METHODS: Thirty-four patients with IPF according to the ATS/ERS criteria underwent PFTs, Medical Research Council (MRC) dyspnea scoring, 6-min walking distance (6-MWD) and radiographic evaluation of fibrosis (HRCT score).
RESULTS: The 6-MWD (% pred.) was more impaired than PFTs. Residual volume (RV) showed the best correlation with the extent of fibrosis (r = -0.67, p = 0.0001) and, together with the alveolar-arterial gradient for O(2) [DeltaP(A - a)O(2)], was an independent predictor of disease extent (R(2) = 0.44). PFTs showed significant though weak correlations with MRC score and 6-MWD. According to the regression analysis, DL(CO) and the HRCT fibrosis score were independent predictors of dyspnea, though they explained only 28% of the overall variance. FEV(1) and DeltaP(A - a)O(2) were independent predictors of 6-MWD (R(2) = 0.31).
CONCLUSIONS: PFTs and lung volumes in particular are closely related to the HRCT score, a measure of the extent of IPF. The correlation of dyspnea score and 6-MWD to PFTs is limited, due to the complexity of mechanisms leading to exercise limitation in IPF. Therefore dyspnea and exercise performance are largely independent indices and should be followed together with PFTs and HRCT score in order to better assess the status and progress of IPF patients.

Entities:  

Mesh:

Year:  2005        PMID: 16484770     DOI: 10.1159/000089656

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  13 in total

1.  Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.

Authors:  Hana Serajeddini; Paola Rogliani; Marco Mura
Journal:  Lung       Date:  2018-08-27       Impact factor: 2.584

2.  Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis.

Authors:  Jennifer M Wang; Scott H Robertson; Ziyi Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Rose Marie Smigla; Thomas G O'Riordan; John Sundy; Lukas Ebner; Craig R Rackley; Page McAdams; Bastiaan Driehuys
Journal:  Thorax       Date:  2017-08-31       Impact factor: 9.139

3.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

4.  Effect of lung fibrosis on glycogen content in different extrapulmonary tissues.

Authors:  Elizabeth Lage Borges; Marina de Barros Pinheiro; Luana Oliveira Prata; Wesley Araújo Sales; Yuri Augusto Junqueira Belém Silva; Marcelo Vidigal Caliari; Maria Glória Rodrigues-Machado; Maria da Glória Rodrigues-Machado
Journal:  Lung       Date:  2013-12-03       Impact factor: 2.584

5.  Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.

Authors:  Mary K Porteous; Belinda N Rivera-Lebron; Maryl Kreider; James Lee; Steven M Kawut
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

6.  Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis.

Authors:  Keishi Sugino; Hiroshige Shimizu; Yasuhiko Nakamura; Takuma Isshiki; Keiko Matsumoto; Sakae Homma
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

7.  A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis.

Authors:  Charles Sharp; Huzaifa I Adamali; Ann B Millar
Journal:  ERJ Open Res       Date:  2017-03-14

8.  Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study.

Authors:  Yan Hua Zhou; Yim Wah Mak
Journal:  Int J Environ Res Public Health       Date:  2017-10-24       Impact factor: 3.390

9.  The correlation of symptoms, pulmonary function tests and exercise testing with high-resolution computed tomography in patients with idiopathic interstitial pneumonia in a tertiary care hospital in South India.

Authors:  Barney Thomas Jesudason Isaac; Balamugesh Thangakunam; Rekha A Cherian; Devasahayam Jesudas Christopher
Journal:  Lung India       Date:  2015 Nov-Dec

10.  A score without diffusion capacity of the lung for carbon monoxide for estimating survival in idiopathic pulmonary fibrosis.

Authors:  Cesar Yoshito Fukuda; Maria Raquel Soares; Carlos Alberto de Castro Pereira
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.